However, compared to T2DM patients, LADY patients have less obesity, hypertension, dyslipidemia, insulin resistance, lower fasting C-peptide (FCP) levels, and higher adiponectin levels (10, 33). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.